Regulatory Oversight and Market Dynamics in American Pain Management

adicionou um novo artigo Iniciativas de Impacto

2026-02-09 07:47:05 -

The United States represents a significant portion of the global demand for gabapentinoids, driven by an aging demographic and a high prevalence of chronic pain conditions. The US Gabapentin Market is currently navigating a complex landscape of high demand and increased regulatory scrutiny. While the drug is FDA-approved for specific indications like epilepsy and postherpetic neuralgia, its...

0 Comentários 0 Compartilhamentos 0 Anterior